Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Equillium, Inc.

< Previous 1 2 Next >
Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium to Present at the Stifel Virtual Inflammation & Immunology Summit
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium to Present at the Wells Fargo Healthcare Conference and the H.C. Wainwright 26th Annual Global Investor Conference
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium Announces Positive Interim Analysis from Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium Announces Second Quarter 2024 Estimated Cash and Investments Balance
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium to Participate in Upcoming Investor Conferences
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium to be included in the Russell Microcap® Index
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium to Present at the Jefferies Global Healthcare Conference
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational Conference
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of Nephrology
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium to Host Analyst & Investor Day
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium to Present at the JonesTrading 2023 Healthcare Summit
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium to Present at the Cantor Fitzgerald Global Healthcare & LD Micro Main Event Conferences
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium to Attend Wells Fargo Healthcare Conference & Present at H.C. Wainwright 25th Annual Global Investor Conference
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium Reports Second Quarter 2023 Financial Results and Provides Corporate and Clinical Updates
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium Announces $7.5 Million Share Repurchase Program
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium to Present at the Jefferies Global Healthcare & LD Micro Invitational Conferences
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium Reports First Quarter 2023 Financial Results and Provides Clinical Updates
From Equillium, Inc.
Via Business Wire
Tickers EQ
Equillium Announces Poster Presentation at the Annual Meeting of the European Society for Blood and Marrow Transplantation
From Equillium, Inc.
Via Business Wire
Tickers EQ
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.